Related Experiment Video
Updated: Sep 27, 2025
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.4K
Stereotactic radiotherapy for lung oligometastases.
Lorenzo Falcinelli1, Claudia Menichelli2, Franco Casamassima2
1Radiation Oncology Section, University of Perugia and Perugia General Hospital, Italy.
Summary
Stereotactic radiotherapy (SRT) is ideal for treating lung metastases, offering high tumor control rates up to 91% at 3 years with limited toxicity. Advanced imaging like PET-CT aids precise treatment planning for better outcomes.
Area of Science:
- Oncology
- Radiation Oncology
- Medical Imaging
Background:
- Lung metastases affect 30-60% of cancer patients, originating from various primary tumors.
- Stereotactic radiotherapy (SRT) is the preferred treatment for pulmonary metastases.
- Accurate staging and treatment planning are crucial for effective management.
Purpose of the Study:
- To provide an overview of technical and clinical aspects of SRT for lung metastases.
- To discuss treatment planning, dose constraints, outcomes, and toxicity.
- To highlight the role of advanced imaging in SRT.
Main Methods:
- Review of current practices in lung metastasis management.
- Discussion of diagnostic imaging modalities including CT and PET-CT.
- Analysis of SRT treatment planning, including respiratory management and image co-registration.
- Examination of dose fractionation schedules and biological effective dose (BED10).
Main Results:
- SRT offers high local control rates (up to 91% at 3 years) with manageable toxicity.
- PET-CT enhances diagnostic accuracy for staging and treatment planning compared to CT alone.
- A BED10 > 100 Gy is recommended for optimal local control, irrespective of fractionation.
- Single-fraction SRT is an option for smaller lesions.
Conclusions:
- SRT is a highly effective modality for treating lung metastases.
- Optimized treatment planning incorporating advanced imaging and respiratory management improves outcomes.
- Adherence to recommended dose constraints ensures high tumor control and minimizes toxicity.
